Gilead Crash Sparks Biotechs' Biggest Drop In 7 Weeks To Key Technical Level
February 04, 2015 at 11:09 AM EST
Despite headlines proclaiming better-than-expected earnings Gilead is collapsing this morning (down around 10%) on the heels of concerns that drug discounts were larger than expected (and thus 2015 revenue expectations will be lower).
